Related Experiment Video
Updated: Aug 25, 2025
Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
Molecular diagnostics in neurotrauma: Are there reliable biomarkers and effective methods for their detection?
Davran Sabirov1, Sergei Ogurcov2, Irina Baichurina1
1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Abstract:
To date, a large number of studies are being carried out in the field of neurotrauma, researchers not only establish the molecular mechanisms of the course of the disorders, but are also involved in the search for effective biomarkers for early prediction of the outcome and therapeutic intervention. Particular attention is paid to traumatic brain injury and spinal cord injury, due to the complex cascade of reactions in primary and secondary injury that affect pathophysiological processes and regenerative potential of the central nervous system. Despite a wide range of methods available methods to study biomarkers that correlate with the severity and degree of recovery in traumatic brain injury and spinal cord injury, development of reliable test systems for clinical use continues. In this review, we evaluate the results of recent studies looking for various molecules acting as biomarkers in the abovementioned neurotrauma. We also summarize the current knowledge of new methods for studying biological molecules, analyzing their sensitivity and limitations, as well as reproducibility of results. In this review, we also highlight the importance of developing reliable and reproducible protocols to identify diagnostic and prognostic biomolecules.
Insights
Researchers are identifying biomarkers for neurotrauma, focusing on traumatic brain and spinal cord injuries. Developing reliable tests is crucial for predicting outcomes and guiding treatment.
Area of Science:
- Neuroscience
- Biomarker Discovery
- Traumatic Injury Research
Background:
- Neurotrauma research investigates molecular mechanisms and biomarkers for predicting outcomes.
- Traumatic brain and spinal cord injuries involve complex pathophysiological processes affecting central nervous system regeneration.
- Current methods for studying biomarkers in neurotrauma have limitations in clinical application.
Purpose of the Study:
- To review recent studies identifying molecules as biomarkers for neurotrauma.
- To summarize knowledge on new methods for studying biological molecules in neurotrauma.
- To highlight the need for reliable protocols for diagnostic and prognostic biomolecules.
Main Methods:
- Literature review of recent studies on neurotrauma biomarkers.
- Analysis of current methods for biomarker detection, sensitivity, and reproducibility.
- Evaluation of molecules associated with traumatic brain injury and spinal cord injury outcomes.
Main Results:
- Numerous studies are exploring various molecules as potential neurotrauma biomarkers.
- New methods for biomarker analysis are emerging, with varying sensitivity and limitations.
- Reproducibility of results remains a challenge in biomarker research for neurotrauma.
Conclusions:
- Effective biomarkers are essential for early prediction and therapeutic intervention in neurotrauma.
- Development of reliable and reproducible test systems is critical for clinical translation.
- Further research is needed to validate diagnostic and prognostic biomolecules for neurotrauma.
